EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 26-Oct-2026 18:17 ET (26-Oct-2026 22:17 GMT/UTC)

Researchers identify why bone marrow scarring occurs in myelofibrosis

Boston Children's Hospital
Peer-Reviewed Publication

In a new study published in Nature Communications, Boston Children’s Hospital researchers have identified a new target responsible for scar formation in the bone marrow of patients with a type of blood cancer known as myelofibrosis. Combining traditional myelofibrosis therapy with drugs that block the scar formation may be a more effective method for treating patients with the disease.

Journal: Nature Communications

Rice360 project aims to bring faster breast cancer diagnosis to rural Texas

Rice University
Grant and Award Announcement

A project led by Rice University’s Rice360 Institute for Global Health Technologies aimed at making breast cancer diagnosis faster and more accessible in rural and medically underserved communities across Texas has received support from the Hill Prizes program.

NIH awards $7.5 million to study whether “forever chemicals” increase the risk of liver and endometrial cancers

Keck School of Medicine of USC
Grant and Award Announcement

USC researchers have received two National Institutes of Health grants totaling $7.5 million to investigate whether exposure to per- and polyfluoroalkyl substances (PFAS), often called “forever chemicals,” may increase the risk of liver and endometrial cancers. The studies will examine pre-diagnostic blood samples and laboratory models to identify how PFAS may contribute to cancer development and to explore how factors such as neighborhood, income and food access may influence exposure and risk.

NRG Oncology trial results show favorable bowel health related quality of life outcomes for localized immediate risk prostate cancer treated with stereotactic body radiation therapy – Results published

NRG Oncology
Peer-Reviewed Publication

PHILADELPHIA, PA – Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) to moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate risk prostate cancer indicate that the use of SBRT improved bowel health related quality of life (HRQOL) in this patient population. There was no significant improvement for SBRT seen for the other primary objectives including urinary HRQOL and disease-free survival. These results are now published in the Journal of the American Medical Association (JAMA) following the presentation during the Plenary Session of the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco, California.

Journal: Journal of the American Medical Association

Standard tests can miss “chemobrain” memory issues

De Gruyter Brill
Peer-Reviewed Publication

Story-based testing reveals undetected memory difficulties in breast cancer survivors.

Journal: Translational Neuroscience

Researchers to lead $3.3 million project to study opioid treatment during breastfeeding

Binghamton University
Grant and Award Announcement

Researchers at Binghamton University, State University of New York have been awarded a $3.3 million grant from the National Institutes of Health to study drug transfer through human breast milk.

Removing immune ‘brake’ improves CAR T–cell therapy for osteosarcoma

St. Jude Children's Research Hospital
Peer-Reviewed Publication

Explore a cellular immunotherapy that controlled relapsed bone cancer and prevented metastasis in model systems, setting the foundation for a clinical trial.

Journal: Cell Reports Medicine

This is how to treat cancer with teacher cells and tumor pieces

University of California - San Francisco
Peer-Reviewed Publication

The immune system possesses legions of T cells that, if they were primed, could hunt down and destroy tumors. Now, a UC San Francisco team has invented a way to do this by combining immune cells that are grown in the lab with samples from a patient’s tumor.

Journal: Cell Stem Cell
Funder: California Institute for Regenerative Medicine, NIH Cancer Moonshot Award, Sandler Program for Breakthrough Biomedical Research New Frontiers Award, Benioff Initiative for Prostate Cancer Research, California Institute for Regenerative Medicine

mRNA immunotherapy developed by UMass Chan scientists eliminates pancreatic tumors in mice

UMass Chan Medical School
Peer-Reviewed Publication

Inspired by the work of the RNA Therapeutics Institute at UMass Chan Medical School and the development of the COVID vaccine, UMass Chan scientistis Marcus Ruscetti, PhD, and Chaitanya Naimesh Parikh, PhD’26, have developed an immunotherapy using a cocktail of messenger RNAs (mRNA) that could potentially be transformative for pancreatic cancer treatment.

Journal: Nature Communications

PCORI awards funding for new patient-centered healthcare research to inform healthcare decisions

Patient-Centered Outcomes Research Institute
Grant and Award Announcement

The Patient-Centered Outcomes Research Institute (PCORI) announced funding for new patient-centered comparative clinical effectiveness research (CER) and related projects to inform clinical practice. The projects span emergency, hospital and outpatient care and address a range of health concerns including cancer, cardiovascular disease, mental and behavioral health, women’s health, pediatric care, rare diseases and chronic disease management.

71
72
73
74
75